Location: Greenwich, CT
CIK: 0001577524 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $782M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALKS | ALKERMES PLC | 8,964,640 | $253M | 32.3% | $21.05 | +29.4% | SHS | G01767105 |
| BIIB | BIOGEN INC | 643,000 | $179M | 22.9% | $278.12 | -0.5% | COM | 09062X103 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 16,390,000 | $172M | 22.1% | $11.52 | -2.7% | COM CL A | 46333X108 |
| INVA | INNOVIVA INC | 6,614,000 | $74.41M | 9.5% | $13.07 | -7.2% | COM | 45781M101 |
| GILD | GILEAD SCIENCES INC | 850,000 | $70.52M | 9.0% | $53.90 | +38.6% | COM | 375558103 |
| — | MERSANA THERAPEUTICS INC | 3,800,000 | $15.62M | 2.0% | $9.56 | — | COM | 59045L106 |
| — | AMARIN CORP PLC | 4,910,000 | $7.365M | 0.9% | $3.92 | — | SPONS ADR NEW | 023111206 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 775,000 | $6.463M | 0.8% | $4.84 | +98.9% | COM | 09058V103 |
| — | VOR BIOPHARMA INC | 618,000 | $3.325M | 0.4% | $43.10 | — | COM | 929033108 |
| — | REGULUS THERAPEUTICS INC | 185,183 | $157K | 0.0% | $2.07 | — | COM | 75915K309 |
| — | PEAR THERAPEUTICS INC | 500,356 | $128K | 0.0% | $6.20 | — | CLASS A COM | 704723105 |